
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
FRANKLIN LAKES, N.J., Oct. 22, 2025 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies at-home sample collection for patients and further automates lab processing using high-tech robotics with the BD COR™ System.








